Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


25.09.2017

2 Biochem Biophys Res Commun
1 BMC Cancer
1 Br J Dermatol
2 Cancer Lett
1 Clin Cancer Res
2 Curr Opin Oncol
2 J Am Acad Dermatol
1 J Clin Oncol
1 J Immunol
1 J Immunother
1 J Invest Dermatol
1 Lancet Oncol
1 Oncogene
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. ZHAO H, Tang W, Chen X, Wang S, et al
    The NAMPT/E2F2/SIRT1 axis promotes proliferation and inhibits p53-dependent apoptosis in human melanoma cells.
    Biochem Biophys Res Commun. 2017 Sep 15. pii: S0006-291X(17)31842.
    PubMed     Text format     Abstract available

  2. XU C, Ruan B, Jiang Y, Xue T, et al
    Antibiotics-induced gut microbiota dysbiosis promotes tumor initiation via affecting APC-Th1 development in mice.
    Biochem Biophys Res Commun. 2017;488:418-424.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. VAN DER HIEL B, Haanen JBAG, Stokkel MPM, Peeper DS, et al
    Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter st
    BMC Cancer. 2017;17:649.
    PubMed     Text format     Abstract available


    Br J Dermatol

  4. GUITERA P, Menzies SW, Argenziano G, Longo C, et al
    Dermoscopy and in vivo confocal microscopy are complimentary techniques for the diagnosis of difficult amelanotic and light colored skin lesions.
    Br J Dermatol. 2016 May 13. doi: 10.1111/bjd.14749.
    PubMed     Text format     Abstract available


    Cancer Lett

  5. HUANG GX, Wang Y, Su J, Zhou P, et al
    Up-regulation of Rho-associated kinase 1/2 by glucocorticoids promotes migration, invasion and metastasis of melanoma.
    Cancer Lett. 2017 Sep 15. pii: S0304-3835(17)30552.
    PubMed     Text format     Abstract available

  6. AIDA S, Sonobe Y, Tanimura H, Oikawa N, et al
    MITF suppression improves the sensitivity of melanoma cells to a BRAF inhibitor.
    Cancer Lett. 2017 Sep 15. pii: S0304-3835(17)30555.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. BARTOLOME RA, Aizpurua C, Jaen M, Torres S, et al
    Monoclonal antibodies directed against cadherin RGD exhibit therapeutic activity against melanoma and colorectal cancer metastasis.
    Clin Cancer Res. 2017 Sep 15. pii: clincanres.1444.2017.
    PubMed     Text format     Abstract available


    Curr Opin Oncol

  8. WARNER SG, O'Leary MP, Fong Y
    Therapeutic oncolytic viruses: clinical advances and future directions.
    Curr Opin Oncol. 2017;29:359-365.
    PubMed     Text format     Abstract available

  9. SILVA IP, Long GV
    Systemic therapy in advanced melanoma: integrating targeted therapy and immunotherapy into clinical practice.
    Curr Opin Oncol. 2017 Sep 12. doi: 10.1097/CCO.0000000000000405.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  10. WOODCOCK JL, Eyre ZW, Stoddard GJ, Callis Duffin K, et al
    Clinical and pathologic factors associated with deep transection of biopsies of invasive melanoma.
    J Am Acad Dermatol. 2017;77:766-768.
    PubMed     Text format    

  11. AYUBI E, Safiri S
    Reply to "Clinical and pathologic factors associated with subclinical spread of invasive melanoma": Statistical and methodological issues.
    J Am Acad Dermatol. 2017;77:e113.
    PubMed     Text format    


    J Clin Oncol

  12. SZNOL M, Ferrucci PF, Hogg D, Atkins MB, et al
    Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma.
    J Clin Oncol. 2017 Sep 15:JCO2016721167. doi: 10.1200/JCO.2016.72.1167.
    PubMed     Text format     Abstract available


    J Immunol

  13. ZILIO S, Vella JL, De la Fuente AC, Daftarian PM, et al
    4PD Functionalized Dendrimers: A Flexible Tool for In Vivo Gene Silencing of Tumor-Educated Myeloid Cells.
    J Immunol. 2017;198:4166-4177.
    PubMed     Text format     Abstract available


    J Immunother

  14. ZECCHINI JM, Kim S, Yum K, Friedlander P, et al
    Development of Bell's Palsy After Treatment With Ipilimumab and Nivolumab for Metastatic Melanoma: A Case Report.
    J Immunother. 2017 Sep 18. doi: 10.1097/CJI.0000000000000184.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  15. HEPPT MV, Wang JX, Hristova DM, Wei Z, et al
    MSX1-induced neural crest-like reprogramming promotes melanoma progression.
    J Invest Dermatol. 2017 Sep 16. pii: S0022-202X(17)32807.
    PubMed     Text format     Abstract available


    Lancet Oncol

  16. TURAJLIC S, Litchfield K, Xu H, Rosenthal R, et al
    Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.
    Lancet Oncol. 2017;18:1009-1021.
    PubMed     Text format     Abstract available


    Oncogene

  17. PEREGO M, Maurer M, Wang JX, Shaffer S, et al
    A slow-cycling subpopulation of melanoma cells with highly invasive properties.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    PLoS One

  18. ZHA L, He L, Xie W, Cheng J, et al
    Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis.
    PLoS One. 2017;12:e0177964.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: